Developing an India Strategy: Practical Considerations to Seek Opportunities and Mitigate Corruption Risks in the Medical Products Sector

President Biden Issues Executive Order Requiring COVID-19 Safeguards for US Government Prime Contractors and Subcontractors

New Developments in China’s Drug Change Management Regulations

FDA Seeks Comments on Transition of Certain Drugs to Device Status Following Genus DC Circuit Decision